A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncology.
Journal Information
Full Title: CPT Pharmacometrics Syst Pharmacol
Abbreviation: CPT Pharmacometrics Syst Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"data s1 click here for additional data file."
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST STATEMENT J.S. and B.C.G. are employed by F. Hoffmann‐La Roche Ltd. C.C., R.A., J.M., C.M., T.T., A.B., and N.F. are employed by F. Hoffmann‐La Roche Ltd. and own Roche stock or stock options. L.E.F. works as an advisor for Pharmetheus AB, a company for pharmacometric services. S.J. is an employee at Pharmetheus AB, a company for pharmacometric services."
Funding Disclosure
Evidence found in paper:
"FUNDING INFORMATION This study was funded by F. Hoffmann‐La Roche Ltd."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025